ZALICUS

Zalicus Inc., formerly CombinatoRx, Incorporated, is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain and inflammation. The Company has devoted substantially all of its resources to the development of its drug discovery technology and the research and development of its drug candidates, including conducting preclinical and clinical trials and seeking intellectual property protection for its technology and product candidates. On March 1, 2010... , the United States Food and Drug Administration, (FDA), approved the New Drug Application (NDA) for Exalgo (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time. On December 21, 2009, the Company merged with Neuromed Pharmaceuticals, Inc. and its subsidiaries.

#People #Financial #Website #More

ZALICUS

Social Links:

Industry:

Biotechnology Health Care Medical

Founded:

2000-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.zalicus.com

Total Employee:

11+

Status:

Active

Contact:

6173017010

Total Funding:

84.98 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network Amazon OpenResty AdBlock Acceptable Ads Citrix NetScaler Bodis DNS

Current Advisors List

pat-fortune_image

Pat Fortune Board of Directors @ Zalicus
Board_member

Current Employees Featured

not_available_image

Christopher C. Gallen
Christopher C. Gallen Executive Vice President, Research and Development @ Zalicus
Executive Vice President, Research and Development

mark-corrigan_image

Mark Corrigan
Mark Corrigan President and CEO @ Zalicus
President and CEO

not_available_image

Justin A. Renz
Justin A. Renz Senior Vice President, CFO and Treasurer @ Zalicus
Senior Vice President, CFO and Treasurer

Stock Details

Company's stock symbol is NASDAQ:CRXX

Acquisitions List

Date	Company	Article	Price
2009-12-21	Neuromed Pharmaceuticals	Neuromed Pharmaceuticals acquired by Zalicus	N/A

Investors List

tl-ventures_image

Official Site Inspections

http://www.zalicus.com

Host Informations
Whois Informations

Loading ...